Skip to content

Clinical Study of Erandadi Guggulu and Sagni Upnah Sweda in The Management of Sandhigat Vata WSR Osteoarthritis

A Clinical Study To Evaluate The Efficacy of Erandadi Guggulu and Sagni Upnah Sweda in The Management of Sandhigat Vata WSR Osteoarthritis

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/050090
Enrollment
60
Registered
2023-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

Department of Kayachikitsa Shri Narayan Prasad Awasthi Govt Ayurved College Raipur Chhattisgarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient will be take between the age of 18 to 70 years without diffrence of age,sex and religion. it is based on Clinical signs and symptoms mentioned in ayurvedic and modern classics of sandhigat vata (ostioarthiritis), especially joint pain,swelling, stiffness,extension,contraction.

Exclusion criteria

Exclusion criteria: 1. Patients below 18 years and above 70 years of age will not be taken. 2. Patients who develop a secondary complication e.g. pleuro-pericardial disease. severely damaged joint with bedridden patients and severe crippling deformities. 3. Patients having neoplasm of the spine, gout, ankylosing spondylitis, traumatic arthritis, and pyogenic osteomyelitis. 4. Patients suffering from paralysis, Liver cirrhosis, Liver failure, Hepatocellular or any carcinoma, and Ascites. 5. Patients having associated cardiac disease, pulmonary tuberculosis, uncontrolled diabetes mellitus, malignant hypertension, renal function impairment, etc. 6. Pregnant and lactating mother. 7. Patients who are taken steroids. 8. Other joint disorders like Gout, RA. traumatic injury The patient mentioned above who is suffering from any severe disease will come under the category of exclusion

Design outcomes

Primary

MeasureTime frame
reduce the symptoms of sandhigat vataTimepoint: 8 WEEKS

Secondary

MeasureTime frame
improve the quality of lifeTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Jeevan Lal Sahu

Shri Narayan Prasad Awasthi Government Ayurved College,Raipur Chhattisgarh

arunaojha90@gmail.com9424401858

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026